SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-16-021971
Filing Date
2016-12-12
Accepted
2016-12-12 10:10:30
Documents
1
Period of Report
2016-12-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_148155541708724.html 4  
1 FORM 4 wf-form4_148155541708724.xml 4 4114
  Complete submission text file 0001628280-16-021971.txt   5574
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LINDE NORTH AMERICA INC. 575 MOUNTAIN AVENUE MURRAY HILL NJ 07974
Business Address
Luehring Jens (Reporting) CIK: 0001631764 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 162045526